|
ATP13A3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.01819999998032E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.160400E-03 |
| Normal-vs-Stage2 |
1.724310E-02 |
| Normal-vs-Stage3 |
9.762000E-03 |
| Normal-vs-Stage4 |
6.131900E-02 |
| Stage1-vs-Stage2 |
3.486000E-01 |
| Stage1-vs-Stage3 |
6.668400E-02 |
| Stage1-vs-Stage4 |
8.751700E-02 |
| Stage2-vs-Stage3 |
2.316400E-01 |
| Stage2-vs-Stage4 |
4.123600E-01 |
| Stage3-vs-Stage4 |
7.847800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.232940E-04 |
| Normal-vs-AfricanAmerican |
8.356200E-04 |
| Normal-vs-Asian |
1.968580E-01 |
| Caucasian-vs-AfricanAmerican |
2.797200E-01 |
| Caucasian-vs-Asian |
5.408400E-01 |
| AfricanAmerican-vs-Asian |
8.429600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.264110E-03 |
| Normal-vs-Female |
3.45000000012696E-07 |
| Male-vs-Female |
3.840700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.728010E-02 |
| Normal-vs-Extreme_Weight |
6.166400E-02 |
| Normal-vs-Obese |
2.043700E-03 |
| Normal-vs-Extreme_Obese |
5.627600E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.797570E-01 |
| Normal_Weight-vs-Obese |
9.464400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.187000E-01 |
| Extreme_Weight-vs-Obese |
8.256300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.462300E-02 |
| Obese-vs-Extreme_Obese |
6.108600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.635600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.19899999823292E-08 |
| Normal-vs-Age(61-80Yrs) |
2.605800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.277800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.945200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.337600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.268400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.157200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.723500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.499200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.60365999999357E-05 |
| Normal-VS-Type2 PRCC |
1.212840E-01 |
| Normal-VS-KIRP CIMP |
1.257840E-02 |
| Normal-VS-Unclassified PRCC |
1.235110E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.351600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.230300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.545600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.056300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.518400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.272000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.855890E-02 |
| Normal-vs-N1 |
1.204070E-02 |
| Normal-vs-N2 |
4.051000E-01 |
| N0-vs-N1 |
7.191700E-02 |
| N0-vs-N2 |
5.465600E-01 |
| N1-vs-N2 |
9.907800E-01 |
|
|
